Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever-Reference-Cited by-同舟云学术

Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever

Published:2007-03-15 Issue:6 Volume:64 Page:637-643
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Wingard John R.¹,Leather Helen L.²,Wood Craig A.³,Gerth William C.⁴,Lupinacci Robert J.,Berger Marc L.⁴,Mansley Edward C.⁵

Affiliation:

1. Blood and Marrow Transplant Program, and Deputy Director of the Gainesville Campus, Division of Hematology and Oncology, College of Medicine, University of Florida Shands Cancer Center, Gainesville

2. Bone Marrow Transplantation/Leukemia, Shands at the University of Florida, Gainesville

3. Infectious Diseases

4. Outcomes Research

5. Health Economics, Merck & Co., Inc., West Point, PA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/64/6/637/28326405/ajhp0637.pdf

Reference34 articles.

1. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

2. Empiric antifungal therapy in febrile granulocytopenic patients

3. 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

4. Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

5. Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species;Antimicrobial Agents and Chemotherapy;2018-06

2. Burden of acute kidney injury in HIV patients under deoxycholate amphotericin B therapy for cryptococcal meningitis and cost-minimization analysis of amphotericin B lipid complex;Medical Mycology;2018-05-14

3. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species;BMC Infectious Diseases;2017-07-10

4. Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses;Expert Review of Pharmacoeconomics & Outcomes Research;2016-06-30

5. Controlling the Capture and Release of DNA with a Dual-Responsive Cationic Surfactant;ACS Applied Materials & Interfaces;2015-04-15